(S)-Methyl 2-(piperidin-3-yl)acetate hydrochloride, 95.0%, 5g

methyl 1-{[(benzyloxy)carbonyl]amino}cyclopropane-1-carboxylate, 95.0%, 250mg

(S)-3-((((9H-Fluoren-9-yl)methoxy)carbonyl)(methyl)amino)butanoic acid, 98+%, 100mg

1-Oxetan-3-yl-piperazine, 95.0%, 250mg

ethyl 2,3-dioxoindoline-5-carboxylate, 95.0%, 1g

Succinic acid, min. 99%, for synthesis, , 250 g, plastic packaging.

((3-Bromo-2-methylpropoxy)methyl)benzene, 95.0%, 5g

Butyl 2-Chloroethyl Ether>98.0%(GC)25mL

Sample vials ROTILABO® with short thread ND9, Clear glass, with solid conical base, 1.1 ml, 100 Piece(s)

3-Bromopropylamine Hydrobromide>98.0%(T)100g

3-(3,5-Dichlorophenoxy)benzaldehyde, 95.0%, 100mg

4-Methylcyclohexanamine hydrochloride, 95.0%, 250mg

O4-Benzyl O1-tert-Butyl 2,3-dihydropyrazine-1,4-dicarboxylate, 98+%, 25g